Under this licensing deal, Hetero will be allowed to expand access of Molnupiravir in India and in other low-and middle-income countries (LMICs), following the approvals for emergency use authorisation.
The antiviral MK-4482 significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection, according to a new study from the US National Institutes of Health scientists.
Further research will have to determine whether humans can tolerate a high dose of favipiravir, favipiravir -- a broad-spectrum antiviral drug used in Japan to treat influenza -- for four to five days.
